Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Atossa Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 92 | 2 | 83 | −7 |
| Shares | 39.3M | 1.91K | 35.8M | −3.50M (−8.9%) |
| Value | $63.3M | $3.00K | $45.4M | −$17.9M (−28.2%) |
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 362,072 | $453.0K | 0.19% |
| Franklin Resources Inc | 71,273 | $89.0K | 0.00% |
| Gsa Capital Partners LLP | 66,223 | $83.0K | 0.01% |
| Ameriprise Financial Inc | 14,407 | $18.0K | 0.00% |
| Amalgamated Financial Corp. | 14,526 | $18.0K | 0.00% |
| Marathon Trading Investment Management LLC | 10,000 | $13.0K | 0.01% |
| Nisa Investment Advisors, LLC | 8,300 | $10.0K | 0.00% |
| Aquatic Capital Management LLC | 4,400 | $6.00K | 0.01% |
| FMR LLC | 1,109 | $1.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 250 | $0 | 0.00% |
| Hantz Financial Services, Inc. | 82 | $0 | 0.00% |
| Ellevest, Inc. | 41 | $0 | 0.00% |
Sold out (19)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Qube Research & Technologies Ltd | 287,989 | $461.0K |
| Sculptor Capital LP | 214,500 | $343.0K |
| National Bank of Canada | 131,100 | $210.0K |
| Parametric Portfolio Associates LLC | 88,258 | $141.0K |
| Graham Capital Management, L.P. | 73,105 | $116.0K |
| Millennium Management LLC | 69,236 | $111.0K |
| Engineers Gate Manager LP | 60,809 | $97.0K |
| Squarepoint Ops LLC | 27,522 | $44.0K |
| Cutler Group LP | 24,190 | $38.0K |
| QCM Cayman, Ltd. | 22,301 | $36.0K |
| XTX Topco Ltd | 17,275 | $28.0K |
| Credit Suisse AG | 15,269 | $24.0K |
| Belvedere Trading LLC | 11,518 | $15.0K |
| Dark Forest Capital Management LP | 3,512 | $6.00K |
| Community Bank, N.A. | 1,475 | $2.00K |
| Evoke Wealth, LLC | 775 | $1.00K |
| Richwood Investment Advisors, LLC | 600 | $1.00K |
| Caption Management, LLC | 126 | $0 |
| Snowden Capital Advisors LLC | 300 | $0 |
Not filed for Q1 2022 yet (2)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Harbour Investments, Inc. | 1,711 | $3.00K |
| NEXT Financial Group, Inc | 200 | $0 |